Stark Novus director fund buys 9,000 NRDE shares

Stark Novus Financial Inc. (NRDE) had one insider-related entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (a director), report purchasing 9,000 shares of Common Stock at $1.83 per share on August 25, 2026.

Rhea-AI Filing Summary

Stark Novus Financial Inc. (NRDE) had one insider-related entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (a director), report purchasing 9,000 shares of Common Stock at $1.83 per share on August 25, 2026. Following this open-market or private transaction, the reporting entity holds 772,000 shares directly, subject to pecuniary-interest limitations.

Insider Trade Summary

Net Buyer: 9,000 shares

Net Buy 1 txn

Insider ESOPUS CREEK VALUE SERIES FUND LP - SERIES A

Role Director

Bought 9,000 shs ($16K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.0001 F1	9,000	$1.83	$16K

Holdings After Transaction: Common Stock, par value $0.0001 — 772,000 shares (Direct)

Footnotes (1)

1. F1. The reporting person disclaims ownership of these securities except to the extent of the reporting person's pecuniary interest therein.

Key Figures

Shares purchased: 9,000 shares Purchase price per share: $1.83 per share Shares held after transaction: 772,000 shares +2 more

5 metrics

Shares purchased 9,000 shares Common Stock transaction on August 25, 2026

Purchase price per share $1.83 per share Common Stock, par value $0.0001

Shares held after transaction 772,000 shares Direct holdings of ESOPUS CREEK VALUE SERIES FUND LP - SERIES A after purchase

Number of buy transactions 1 transaction Form 4 transaction summary for August 25, 2026

Net shares bought 9,000 shares Net buy-sell direction reported as net-buy

Key Terms

beneficial ownership, pecuniary interest, Rule 10b5-1, open market or private transaction

4 terms

beneficial ownership financial

"disclaims beneficial ownership of the securities covered by this statement"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of the pecuniary interest of such person"

Rule 10b5-1 regulatory

"aff_10b5_one"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"Purchase in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction was reported for NRDE in this Form 4?

A director-affiliated entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A, reported purchasing 9,000 shares of Stark Novus Financial Inc. Common Stock at $1.83 per share on August 25, 2026, in an open-market or private transaction.

How many NRDE shares does the reporting entity hold after this transaction?

After the reported purchase, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A holds 772,000 shares of Stark Novus Financial Inc. Common Stock directly, as stated in the Form 4 filing.

Was the NRDE insider trade made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating that the 9,000-share purchase of NRDE stock was made pursuant to a Rule 10b5-1 trading plan.

Who is identified in connection with the NRDE reporting person on this Form 4?

The reporting person is ESOPUS CREEK VALUE SERIES FUND LP - SERIES A, a director of Stark Novus Financial Inc. The remarks state that Andrew L. Sole can determine investment and voting decisions but disclaims beneficial ownership except for his pecuniary interest.

What does the Form 4 say about beneficial ownership of NRDE shares?

The Form 4 discloses that the reporting person disclaims beneficial ownership of the reported NRDE securities except to the extent of its pecuniary interest in those securities, limiting the claim of full economic ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 04:37 PM EDT Accepted by SEC EDGAR 08/27/2026 - 04:36 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ESOPUS CREEK VALUE SERIES FUND LP - SERIES A

(Last) (First) (Middle)

C/O ESOPUS CREEK ADVISORS LLC

81 NEWTOWN LANE #307

(Street)

EAST HAMPTON NEW YORK 11937

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Stark Novus Financial Inc. [ SNFI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001(1)	08/25/2026		P		9,000	A	$1.83	772,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person disclaims ownership of these securities except to the extent of the reporting person's pecuniary interest therein.

Remarks:

Andrew L. Sole, as the managing member of the general partner of the Reporting Person, is in a position to determine the investment and voting decisions made by the Reporting Persson. Mr. Sole currently reports his holdings and transactions in the Issuer's securities in separate filings. Mr. Sole disclaims beneficial ownership of the securities covered by this statement except to the extent of the pecuniary interest of such person in such securities.

	/s/ Andrew L. Sole, managing member of Esopus Creek Advisors, LLC, general partner of Esopus Creek Value Series Fund LP - Series A	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)